MedTrace Logo

Pharmacokinetic Study of Cefditoren Pivoxil in Breast Milk and Blood of Lactating Women

NCT06644105 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-10-16

No results posted yet for this study

Summary

The goal of this clinical trial is to provide a theoretical basis for the rational use of cefditoren pivoxil in lactating women by conducting a pharmacokinetic study of cefditoren in the blood and milk of these women. The main questions it aims to answer are:

Can lactating women use cefditoren pivoxil? Is cefditoren distributed in breast milk?

12 Participants will:

Take cefditoren pivoxil tablets 200mg after a meal, and collect breast milk and plasma over certain time periods.

Conditions

  • Medication Safety
  • Drug Safety
  • Drug Metabolism

Interventions

DRUG

cefditoren pivoxil tablets

took cefditoren pivoxil tablets 200mg after

Sponsors & Collaborators

  • West China Second University Hospital

    lead OTHER

Principal Investigators

  • Qin yu · National Drug Clinical Trial Institution of West China Second Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-01-24
Completion
2024-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06644105 on ClinicalTrials.gov